We found that higher expression of the IL1B signature is associated with lower survival rate in multiple cancer types, especially in Low Grade Glioma (LGG) and in Kidney renal cell carcinoma (KIRC) (Supplementary Fig. 10). The gene discussed is IL1B; the disease is glioma.